Latest filing published 06 Oct 2009 for CURAGEN CORP.
No signal scores available.
Paul M. Finigan discloses dealings in Curagen Corp to SEC (Form 4). Between 1 August 2006 and 1 October 2009, the trades on record add up to 16 filings.
The open-market record consists of 10 sales worth €117k, with no purchase. The amount is not disclosed for 1 filing. Other entries cover 3 share grants and 1 option exercise. Since January 2009: no purchases and 10 sales on the market.
On 6 October 2009 came the latest disclosure, a transaction in Curagen Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations